Publications by authors named "Edin Basic"

Claim this Profile
Q
Questioning Conclusions and Statements on the German HTA System: A Critical Perspective.
Jörg Tomeczkowski, Tanja Heidbrede, Friedhelm Leverkus, Sarah Schmitter, Charalabos-Markos Dintsios, Edin Basic

Clin Pharmacol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database.
Christof Scheid, Igor W Blau, Leopold Sellner, Boris A Ratsch, Edin Basic

Eur J Haematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Successful Use of Sirolimus in Renal Transplant Patients.
Marcel G Naik, Jan Steffen Jürgensen, Wolfgang Arns, Edin Basic, Klemens Budde

Transplant Proc· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact analysis of the use of oral and intravenous therapy regimens for the treatment of relapsed or refractory multiple myeloma in Germany.
Edin Basic, Mathias Kappel, Arpit Misra, Leopold Sellner, Boris A Ratsch

Eur J Health Econ· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake in antithrombotic treatment and its association with stroke incidence in atrial fibrillation: insights from a large German claims database.
Stefan H Hohnloser, Edin Basic, Michael Nabauer

Clin Res Cardiol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study.
Stefan H Hohnloser, Edin Basic, Michael Nabauer

Thromb Haemost· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study.
Sebastian Himmler, Malina Müller, Dennis Ostwald, Ahmed Seddik, Edin Basic

Expert Rev Pharmacoecon Outcomes Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Estimating the incidence of venous thromboembolism (VTE) using various types of routine data of the German healthcare system].
Christoph Ohlmeier, Friedhelm Leverkus, Sebastian Kloss, Edin Basic, Hans-Holger Bleß

Z Evid Fortbild Qual Gesundhwes· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation.
Stefan H Hohnloser, Edin Basic, Christopher Hohmann, Michael Nabauer

Thromb Haemost· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative risk of major bleeding with new oral anticoagulants (NOACs) and phenprocoumon in patients with atrial fibrillation: a post-marketing surveillance study.
Stefan H Hohnloser, Edin Basic, Michael Nabauer

Clin Res Cardiol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKC-zeta mediates norepinephrine-induced phospholipase D activation and cell proliferation in VSMC.
Jean-Hugues Parmentier, Philip Smelcer, Zoran Pavicevic, Edin Basic, Azra Idrizovic

Hypertension· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis